<VariationArchive VariationID="1072415" VariationName="NM_006412.4(AGPAT2):c.369_372del (p.Leu124fs)" VariationType="Deletion" Accession="VCV001072415" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1061650" VariationID="1072415">
      <GeneList>
        <Gene Symbol="AGPAT2" FullName="1-acylglycerol-3-phosphate O-acyltransferase 2" GeneID="10555" HGNC_ID="HGNC:325" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136673143" stop="136687457" display_start="136673143" display_stop="136687457" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139567594" stop="139581910" display_start="139567594" display_stop="139581910" Strand="-" />
          </Location>
          <OMIM>603100</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006412.4(AGPAT2):c.369_372del (p.Leu124fs)</Name>
      <CanonicalSPDI>NC_000009.12:136677080:GAGC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136677081" stop="136677084" display_start="136677081" display_stop="136677084" variantLength="4" positionVCF="136677080" referenceAlleleVCF="AGAGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139571533" stop="139571536" display_start="139571533" display_stop="139571536" variantLength="4" positionVCF="139571532" referenceAlleleVCF="AGAGC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L124fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.139571533_139571536del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.139571533_139571536del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.136677081_136677084del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.136677081_136677084del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008090.1" sequenceAccession="NG_008090" sequenceVersion="1" change="g.15376_15379del">
            <Expression>NG_008090.1:g.15376_15379del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012727.2" sequenceAccession="NM_001012727" sequenceVersion="2" change="c.369_372del">
            <Expression>NM_001012727.2:c.369_372del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012745.1" sequenceAccession="NP_001012745" sequenceVersion="1" change="p.Leu124fs">
            <Expression>NP_001012745.1:p.Leu124fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006412.4" sequenceAccession="NM_006412" sequenceVersion="4" change="c.369_372del" MANESelect="true">
            <Expression>NM_006412.4:c.369_372del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006403.2" sequenceAccession="NP_006403" sequenceVersion="2" change="p.Leu124fs">
            <Expression>NP_006403.2:p.Leu124fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1693228350" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006412.4(AGPAT2):c.369_372del (p.Leu124fs) AND not provided" Accession="RCV001385113" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006412.4(AGPAT2):c.369_372del (p.Leu124fs) AND Congenital generalized lipodystrophy type 1" Accession="RCV002246369" Version="1">
        <ClassifiedConditionList TraitSetID="1835">
          <ClassifiedCondition DB="MedGen" ID="C1720862">Congenital generalized lipodystrophy type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11967537</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15181077</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1835" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5410" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 1</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+1/1829" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, AGPAT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BSCL1</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CGL1</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="84" />
                <XRef ID="84" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720862" DB="MedGen" />
              <XRef ID="MONDO:0012071" DB="MONDO" />
              <XRef Type="MIM" ID="608594" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4932430" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000009.12:g.136677081_136677084delGAGC|OMIM:608594" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002517538" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGPAT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.12:g.136677081_136677084delGAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608594" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110505" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="2467936|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001584859" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15181077</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11967537</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in AGPAT2 are known to be pathogenic (PMID: 15181077, 11967537). This variant has not been reported in the literature in individuals with AGPAT2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu124Serfs*26) in the AGPAT2 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGPAT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.139571533_139571536del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3110505" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4932430" TraitType="Disease" MappingType="XRef" MappingValue="608594" MappingRef="OMIM">
        <MedGen CUI="C1720862" Name="Congenital generalized lipodystrophy type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

